ZURICH/GDANSK, Feb 26(Reuters) - Here are some of the main factors that may affect Swiss stocks on Wednesday:
Novartis AG NOVN.S
Emasan AG, an arm of the Sandoz Family Foundation, has launched a public offering of some 26.5 million shares in Swiss pharmaceutical firm Novartis to raise up to $3 billion in an accelerated bookbuilt offering, according to the bookrunner.
COMPANY STATEMENTS
ADECCO ADEN.S
Adecco reports 5% drop in fourth-quarter revenue
GEORG FISCHER GF.S
Proposes A Dividend Of CHF 1.35/Shr
IDORSIA LTD IDIA.S
Idorsia And Viatris Update Collaboration For Selatogrel And Cenerimod
STRAUMANN HOLDING AG STMN.S
CFO Yang Xu To Leave Straumann Group In May 2025
INA INVEST INAI.S
Full Year results posted.
IMPLENIA AG IMPN.S
Full year net income at CHF 93.351 million
MEDMIX MEDX.S
Full Year adjusted EBITDA At CHF 92.5 million
U BLOX UBXN.S
Full year Adjusted EBIT At CHF -59.6 Million
EMMI AG EMMN.S
Full year EBIT At CHF 302.7 Mln
ANALYSTS' VIEWS
SIKA AG SIKA.S - JEFFERIES RAISES TARGET PRICE TO CHF 304 FROM CHF 299
LANDIS+GYR GROUP AG LANDI.S - JP MORGAN CUTS TARGET PRICE TO CHF 58 FROM CHF 76
ECONOMY
Swiss February investor sentiment due at 0900 GMT.
SNB US Dollar auction due at 1000 GMT.
(Reporting by Zurich newsroom and Gdansk newsroom)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.